Trial challenges how doctors decide who needs statins

· Science

A trial of nearly 5,800 adults found that using heart scans measuring calcium buildup in the arteries produced the same observed rate of major cardiovascular events as traditional risk assessments, even though the scans led to statins being recommended to far fewer patients. Unexpectedly, patients advised to take statins based on their scans were nearly as likely to experience events, undercutting assumptions that coronary calcium imaging is a superior way to guide preventive treatment. The results question how doctors should decide who really needs cholesterol-lowering drugs.

Why it matters：If coronary calcium scans do not improve outcomes while cutting statin use, guideline bodies and payers may rethink a widely adopted screening tool that shapes preventive cardiology worldwide.

Key points

  • The trial enrolled nearly 5,800 adults.
  • Scan-guided care recommended statins to far fewer patients.
  • Major cardiovascular event rates were the same as with traditional risk assessment.

Sources (original reporting)

More stories from this day